106
|
309
|
6kjbA |
Wild-type apo-form e. coli atcase holoenzyme with an unusual open conformation of r167 |
121
|
293
|
6pnzA |
The structure of the aspartate transcarbamoylase trimer from staphylococcus aureus complexed with pala at 2.27 resolution. |
121
|
362
|
6hfuA |
Human dihydroorotase mutant f1563y co-crystallized with carbamoyl aspartate at ph 7.5 |
121
|
362
|
6hfrA |
Human dihydroorotase mutant f1563y co-crystallized with carbamoyl aspartate at ph 7.0 |
121
|
362
|
6hfeA |
Human dihydroorotase mutant f1563t apo structure |
122
|
362
|
6hfpA |
Human dihydroorotase mutant f1563t co-crystallized with carbamoyl aspartate at ph 7.0 |
119
|
362
|
6hffA |
Human dihydroorotase mutant f1563y apo structure |
120
|
364
|
6hg2A |
Hybrid dihydroorotase domain of human cad with e. coli flexible loop, bound to fluoroorotate |
120
|
362
|
6hfsA |
Human dihydroorotase mutant f1563y co-crystallized with carbamoyl aspartate at ph 6.5 |
122
|
362
|
6hfqA |
Human dihydroorotase mutant f1563t co-crystallized with carbamoyl aspartate at ph 7.5 |
122
|
362
|
6hfnA |
Human dihydroorotase mutant f1563l co-crystallized with carbamoyl aspartate at ph 7.5 |
119
|
362
|
6hflA |
Human dihydroorotase mutant f1563l co-crystallized with carbamoyl aspartate at ph 7.0 |
122
|
366
|
6hg3A |
Hybrid dihydroorotase domain of human cad with e. coli flexible loop, bound to dihydroorotate |
122
|
345
|
5ilnA |
Crystal structure of aspartate transcarbamoylase from plasmodium falciparum (pfatc) with bound citrate |
121
|
362
|
6hfjA |
Human dihydroorotase mutant f1563a co-crystallized with carbamoyl aspartate at ph 7.5 |
120
|
362
|
6hfdA |
Human dihydroorotase mutant f1563l apo structure |
121
|
363
|
6hfhA |
Human dihydroorotase mutant f1563a co-crystallized with carbamoyl aspartate at ph 7.0 |
120
|
362
|
6hfiA |
Human dihydroorotase mutant f1563a apo structure |
112
|
371
|
6hg1A |
Hybrid dihydroorotase domain of human cad with e. coli flexible loop in apo state |
120
|
362
|
6hfkA |
Human dihydroorotase mutant f1563l co-crystallized with carbamoyl aspartate at ph 6.5 |
110
|
363
|
5ynzA |
Crystal structure of the dihydroorotase domain (k1556a) of human cad |
119
|
310
|
8at1A |
Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and ctp or atp at 2.8-angstroms resolution and neutral p*h |
107
|
310
|
8atcA |
Complex of n-phosphonacetyl-l-aspartate with aspartate carbamoyltransferase. x-ray refinement, analysis of conformational changes and catalytic and allosteric mechanisms |
83
|
310
|
9atcA |
Atcase y165f mutant |
120
|
310
|
7at1A |
Crystal structures of aspartate carbamoyltransferase ligated with phosphonoacetamide, malonate, and ctp or atp at 2.8-angstroms resolution and neutral p*h |
126
|
335
|
6hl7A |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum with mutated active site (r109a/k138a) and n-carbamoyl-l-phosphate bound |
120
|
327
|
6fbaA |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum with bound inhibitor 2,3-naphthalenediol |
120
|
328
|
6fbaC |
Crystal structure of truncated aspartate transcarbamoylase from plasmodium falciparum with bound inhibitor 2,3-naphthalenediol |
102
|
310
|
6at1A |
Structural consequences of effector binding to the t state of aspartate carbamoyltransferase. crystal structures of the unligated and atp-, and ctp-complexed enzymes at 2.6-angstroms resolution |
103
|
310
|
5vmqA |
Structure of the r105a mutant catalytic trimer of escherichia coli aspartate transcarbamoylase at 2.0-a resolution |
108
|
310
|
4f04A |
A second allosteric site in e. coli aspartate transcarbamoylase: r-state atcase with utp bound |
103
|
310
|
4e2fA |
Crystal structure of e. coli aspartate transcarbamoylase k164e/e239k mutant in an intermediate state |
109
|
304
|
4eknB |
Structure of the catalytic chain of methanococcus jannaschii aspartate transcarbamoylase in a hexagonal crystal form |
121
|
363
|
4c6qA |
Crystal structure of the dihydroorotase domain of human cad c1613s mutant bound to substrate at ph 7.0 |
115
|
362
|
4by3A |
Crystal structure of the dihydroorotase domain of human cad in apo- form obtained recombinantly from e. coli. |
116
|
363
|
4c6lA |
Crystal structure of the dihydroorotase domain of human cad bound to the inhibitor fluoroorotate at ph 6.0 |
110
|
380
|
4c6bA |
Crystal structure of the dihydroorotase domain of human cad with incomplete active site, obtained recombinantly from e. coli. |
120
|
362
|
4c6dA |
Crystal structure of the dihydroorotase domain of human cad bound to substrate at ph 6.0 |
120
|
363
|
4c6iA |
Crystal structure of the dihydroorotase domain of human cad bound to substrate at ph 7.0 |
117
|
362
|
4c6cA |
Crystal structure of the dihydroorotase domain of human cad in apo- form obtained recombinantly from hek293 cells. |
116
|
363
|
4c6mA |
Crystal structure of the dihydroorotase domain of human cad bound to the inhibitor fluoroorotate at ph 7.0 |
121
|
363
|
4c6jA |
Crystal structure of the dihydroorotase domain of human cad bound to substrate at ph 7.5 |
123
|
363
|
4c6nA |
Crystal structure of the dihydroorotase domain of human cad e1637t mutant bound to substrate at ph 6.0 |
118
|
362
|
4c6pA |
Crystal structure of the dihydroorotase domain of human cad c1613s mutant in apo-form at ph 7.0 |
119
|
363
|
4c6kA |
Crystal structure of the dihydroorotase domain of human cad bound to substrate at ph 8.0 |
119
|
364
|
4c6eA |
Crystal structure of the dihydroorotase domain of human cad bound to substrate at ph 5.5 |
119
|
364
|
4c6fA |
Crystal structure of the dihydroorotase domain of human cad bound to substrate at ph 6.5 |
118
|
362
|
4c6oA |
Crystal structure of the dihydroorotase domain of human cad c1613s mutant in apo-form at ph 6.0 |
102
|
310
|
4at1A |
Structural consequences of effector binding to the t state of aspartate carbamoyltransferase. crystal structures of the unligated and atp-, and ctp-complexed enzymes at 2.6-angstroms resolution |
118
|
291
|
4bjhB |
Crystal structure of the aquifex reactor complex formed by dihydroorotase (h180a, h232a) with dihydroorotate and aspartate transcarbamoylase with n-(phosphonacetyl)-l-aspartate (pala) |